Kennedy Jr. and the Food and Drug Administration announced a plan to phase out petroleum-based dyes ... Green 3, and Blue 1 and 2.

Eli Lilly and Co., the maker of Zepbound and Mounjaro, announced a successful Phase 3 trial for a once-daily GLP-1 pill for ...

WASHINGTON -- The Department of Health and Human Services (HHS) and the Food and Drug Administration announced on Tuesday a series of measures to phase out ... Blue No. 1 and Blue No. 2.

Pfizer abandoned the development of danuglipron and plans to focus its efforts on GIPR candidates and other earlier obesity programs.

Blue 1 is used in Mountain Dew Baja ... the Biden administration's FDA delivered a ban on Red 3 in food and drinks, giving food companies until 2027 to phase out the dye. "The FDA cannot authorize ...

Sanofi signed a deal with Earendil Labs for $125 million upfront and $1.72 billion in milestone payments. Regeneron Pharmaceuticals signed a deal worth more than $3 billion with contract drug ...

once-daily small-molecule oral GLP-1 receptor agonist that can be administered at any time of the day without restrictions on food and water intake. The phase III ACHIEVE-1 study, the first of ...

WASHINGTON (AP) — U.S. health officials on Tuesday said they would phase ... 1. A broader ban will extend the restrictions to all foods sold in the state on Jan. 1, 2028. Many U.S. food ...

The U.S. Department of Health and Human Services (HHS) and U.S. Food and Drug Administration (FDA) announced new measures this week that will “phase out ... Diet The plan involves multiple ...